$PTHS
Pelthos Therapeutics Inc.
XASE
Why is PTHS up today? It is at $27.25 (+0.00%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PTHS spikes, and full due diligence on PTHS — key stats, earnings, dilution and insider activity. Free.
Get free $PTHS alerts the moment volume spikes
Our scanner flagged $PTHS 6 times in the last 30 days. Create a free account to track $PTHS, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $27.25
- Change today
- +0.00%
- Previous close
- $27.26
- 52-week range
- $16.50 – $37.50
- Market cap
- $94M
- Institutional own.
- 28.41%
- Total held
- 28.4%
- Tradeable float
- 2.5M 72% of shares · after 28% institutions
- Short interest
- 28K ▲ +32% vs prior · as of 2026-06-30
- Short % of float
- 1.1%
- Days to cover
- 1.0d
- Avg daily volume
- 18K
- Next earnings
- Aug 12 · in 22d
- Exchange
- XASE
Get free PTHS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $PTHS moving today?
Here is the latest on PTHS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PTHS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystRegulation FD Disclosure, from the latest SEC filing. Read it →Insiders
1 open-market buy1 buys, 7 sells last 3 months (2/13 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Greenleaf Peter Director | Sold (automatic/other) | -797 0.02% of company | sold 3.2% | 24K | $21K at $26.00 | Jul 2, 26 |
Pauls Matthew Director | Sold (automatic/other) | -786 0.02% of company | sold 5.2% | 14K | $20K at $26.00 | Jul 2, 26 |
Friedberg Ezra M Director | Sold (automatic/other) | -558 0.02% of company | sold 0.7% | 81K | $15K at $26.03 | Jul 2, 26 |
Friedberg Ezra M Director | Sold (automatic/other) | -283 | sold 0.3% | 82K | $8K at $27.12 | Jun 15, 26 |
Davis Todd C Director | Bought (open market) | +36K 1.0% of company | added 90% | 76K | $999K at $27.80 | Jun 11, 26 |
Francis Knuettel Ii Officer | Sold (automatic/other) | -14K 0.4% of company | sold 42% | 20K | n/a | May 22, 26 |
Francis Knuettel Ii Officer | Sold (automatic/other) | -2K 0.04% of company | sold 6.6% | 21K | $40K at $26.84 | May 22, 26 |
Friedberg Ezra M Director | Sold (automatic/other) | -144 | sold 0.2% | 82K | $4K at $27.01 | May 14, 26 |
Greenleaf Peter Director | Sold (automatic/other) | -797 0.02% of company | sold 3.1% | 25K | $16K at $20.52 | Apr 2, 26 |
Pauls Matthew Director | Sold (automatic/other) | -786 0.02% of company | sold 4.9% | 15K | $16K at $20.52 | Apr 2, 26 |
Friedberg Ezra M Director | Sold (automatic/other) | -558 0.02% of company | sold 0.7% | 82K | $11K at $20.51 | Apr 2, 26 |
Malamut Richard Director | Sold (automatic/other) | -590 0.02% of company | sold 2.1% | 27K | $12K at $20.51 | Apr 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $PTHS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$PTHS Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$PTHS Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
PTHS stock FAQ
Why is $PTHS moving today?
Here is the latest on PTHS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PTHS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the PTHS stock price today?
PTHS last traded at $27.25, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does PTHS report earnings?
Pelthos Therapeutics Inc. (PTHS) is next expected to report earnings on Wednesday, August 12, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live PTHS alerts?
The PTHS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PTHS 6 times in the last 30 days.
What exchange is PTHS on?
PTHS (Pelthos Therapeutics Inc.) trades on XASE, with a market cap of about $94M.
Is PTHS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PTHS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.